Prevalence of LasB elastase variants from Pseudomonas aeruginosa respiratory isolates and their inhibition by novel LasB inhibitor ANT3273
A. Llanos (Labège, France), C. Lozano (Labège, France), J. Castandet (Labège, France), M. Zalacain (Labège, France), M. Tunney (Belfast, United Kingdom), R. Mairs (Belfast, United Kingdom), G. Einarsson (Belfast, United Kingdom), M. Everett (Labège, France)
Source: International Congress 2022 – Bronchiectasis: 1
Session: Bronchiectasis: 1
Session type: Thematic Poster
Number: 392
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Llanos (Labège, France), C. Lozano (Labège, France), J. Castandet (Labège, France), M. Zalacain (Labège, France), M. Tunney (Belfast, United Kingdom), R. Mairs (Belfast, United Kingdom), G. Einarsson (Belfast, United Kingdom), M. Everett (Labège, France). Prevalence of LasB elastase variants from Pseudomonas aeruginosa respiratory isolates and their inhibition by novel LasB inhibitor ANT3273. 392
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|